Revenue
434 million USD
2012-12-28 · USD
Exact inputs and evidence
- Revenue: 433912000 USD Source
Fundies. English
PSS WORLD MEDICAL INC
EDGAR76 filing records in this dataset, filed from 1996-05-30 to 2013-02-06. Reported financial figures are available; chart coverage varies by period.
Latest quarter
Operating margin
5.53%
2012-12-28 · %
Operating cash flow
38 million USD
2012-12-28 · USD
- Cash and cash equivalents
- 216 million USD Source
Exact value
216134000 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 50.3 million shares Source
Exact value
50328843 shares
Reported share-count change
-1.74% · -893 thousand shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2013-02-06.
Financial data available through: 2012-03-30.
Coverage by financial measure
- Revenue: 4 of 11 periods available· newest 2012-03-30
- Operating income: 4 of 11 periods available· newest 2012-03-30
- Net income: 4 of 11 periods available· newest 2012-03-30
- Operating cash flow: 4 of 11 periods available· newest 2012-03-30
- Capital expenditure: 1 of 11 periods available· newest 2011-04-01
- Total assets: 4 of 11 periods available· newest 2012-03-30
- Total liabilities: 4 of 11 periods available· newest 2012-03-30
- Current assets: 4 of 11 periods available· newest 2012-03-30
- Current liabilities: 4 of 11 periods available· newest 2012-03-30
- Cash and cash equivalents: 4 of 11 periods available· newest 2012-03-30
- long term debt: No compatible figures in this window
- Shares outstanding: 3 of 11 periods available· newest 2012-03-30
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
No unambiguous prior-year comparison is available for the latest reporting period.
Comparable inputs unavailable for: Revenue, Net income, Operating cash flow, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2012 2011-04-02 – 2012-03-30
- Revenue USD 2.1 billion 100% of revenue
- Operating costs Derived USD 1.97 billion 94% of revenue
- Operating income USD 133.36 million 6.3% of revenue
- Tax, interest and other Derived USD 59.04 million 2.8% of revenue
- Net income USD 74.32 million 3.5% of revenue
Cash
- Operating cash flow USD 128.28 million 6.1% of revenue
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2009 95%
- 2010 94%
- 2011 93%
- 2011 93%
- 2012 94%
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2009 2008-03-29 – 2009-03-27 | 1952691000 | 1851764000 Derived | 100927000 | 49441000 Derived | 51486000 | Unavailable | Source
|
| 2010 2009-03-28 – 2010-04-02 | 2055171000 | 1934190000 Derived | 120981000 | 51618000 Derived | 69363000 | Unavailable | Source
|
| 2011 2010-04-02 – 2011-04-01 | 2034789000 | 1901233000 Derived | 133556000 | 59071000 Derived | 74485000 | 98101000 Derived | Source
|
| 2011 2010-04-03 – 2011-04-01 | 2034789000 | 1901233000 Derived | 133556000 | 59071000 Derived | 74485000 | Unavailable | Source
|
| 2012 2011-04-02 – 2012-03-30 | 2102002000 | 1968646000 Derived | 133356000 | 59037000 Derived | 74319000 | Unavailable | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 2.1B 2012
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2009 | Revenue | 1952691000 |
|
| 2010 | Revenue | 2055171000 |
|
| 2012 | Revenue | 2102002000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
5.2% 2010
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2009 | Year over year | No prior comparable period |
|
| 2010 | Year over year | 5.2% |
|
| 2012 | Year over year | No prior comparable period |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin 6.3% 2012
Net margin 3.5% 2012
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2009 | Operating margin | 5.2% |
|
| 2010 | Operating margin | 5.9% |
|
| 2012 | Operating margin | 6.3% |
|
| 2009 | Net margin | 2.6% |
|
| 2010 | Net margin | 3.4% |
|
| 2012 | Net margin | 3.5% |
|
| 2009 | Free cash flow margin | Not reported |
|
| 2010 | Free cash flow margin | Not reported |
|
| 2012 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD 128.3M 2012
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2009 | Operating cash flow | 90121000 |
|
| 2010 | Operating cash flow | 102401000 |
|
| 2012 | Operating cash flow | 128284000 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2009 | Free cash flow | Unavailable |
|
| 2010 | Free cash flow | Unavailable |
|
| 2012 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
66.2% 2012
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2009 | Liabilities / assets | 56% |
|
| 2010 | Liabilities / assets | 53.2% |
|
| 2012 | Liabilities / assets | 66.2% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
4.07× 2012
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2009 | Current assets / current liabilities | 2.35× |
|
| 2010 | Current assets / current liabilities | 2.91× |
|
| 2012 | Current assets / current liabilities | 4.07× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2009 2008-03-29 – 2009-03-27 | USD 51.49 million Exact valueExact value: 51486000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 90.12 million Exact valueExact value: 90121000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2010 2009-03-28 – 2010-04-02 | USD 69.36 million Exact valueExact value: 69363000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 102.4 million Exact valueExact value: 102401000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2011 2010-04-02 – 2011-04-01 | USD 74.49 million Exact valueExact value: 74485000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 116.33 million Exact valueExact value: 116328000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 18.23 million Exact valueExact value: 18227000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 98.1 million Calculation and evidence116328000 − 18227000 USD Exact free cash flow: 98101000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2011 2010-04-03 – 2011-04-01 | USD 74.49 million Exact valueExact value: 74485000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 116.33 million Exact valueExact value: 116328000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2012 2011-04-02 – 2012-03-30 | USD 74.32 million Exact valueExact value: 74319000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 128.28 million Exact valueExact value: 128284000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
76 filings · 1,796 latest values · 1,796 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0000920527, 920527, edgar:920527
Also known as PHYSICIAN SALES & SERVICE INC /FL/, PSS WORLD MEDICAL INC